Synapse Open Synapse
Biology

Belgian startup revives Galapagos CAR-T research

BioPharma Dive · · 2 min read

Armed Cell Therapeutics, chaired by former Galapagos CEO Paul Stoffels, has assumed control of cell therapies the company — now known as Lakefront Biotherapeutics — divested in a strategic overhaul.

Latest from BioPharma Dive